The Cluster Meeting of Gala Technology 2023 (Galatech-2023) which was held in Holiday Inn Amsterdam Arena Towers on July 12-14, achieved a consummation. This scientific cluster gathering consisted of four parallel conferences together, which are The 18th Annual Congress of International Drug Discovery Science and Technology, The 9th Annual International Symposium of Drug Delivery Systems, The 8th Annual Conference of AnalytiX and The 13th Anniversary of Protein & Peptide Conference. The cluster meeting hosted by World High Technology Society, operated by BIT Group Global, sponsored by Wyatt Technology Division of Waters and supported by International Transmembrane Transporter Society, International Society of Digital Medicine, The Asian Society of Natural Products, UK Pharmacogenetics and Stratified Medicine Network, The Czech Pharmaceutical Society and The National Hospital Pharmacists Association of Romanian. This annual conference brought together nearly 200 specialists from 36 countries and regions.

The Opening Ceremony and Keynote Forum took place on Wednesday’s morning, the keynote forum is sponsored by Wyatt Technology Division of Waters. Dr. Stefan Platz, SVP & Global Head Clinical Pharmacology & Safety Sciences, AstraZeneca, UK, Dr. Luc Van Hijfte, Senior VP Drug Discovery, Symeres B.V., the Netherlands, Dr. Matthew He, Professor, Halmos College of Arts and Sciences, Nova Southeastern University, USA, Dr. Balazs Sarkadi, Professor Emeritus, Research Centre for Natural Sciences, Institute of Enzymology, Hungary, Dr. Roger Scherrers, Head of Analytical Service, Waters, Wyatt Technology Division, Germany, Dr. Robert Kaptein, Emeritus Professor, Bijvoet Center for Biomolecular Research, Utrecht University, the Netherlands and Dr. Matthias von Herrath, Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA gave brilliant plenary speeches. Dr. Matthew He as moderators of the Opening Ceremony and Keynote Forum expressed great gratitude to the presence of all delegates, speakers and participants and particularly wished all the guests a memorable stay in Amsterdam on behalf of the organizing committee.

Plenary Forum

The unique program of Galatech2023 comprised 16 parallel sessions. Hot topics and new ideas on Drug Discovery, Drug Delivery Systems, AnalytiX and Protein & Peptide were hotly discussed and exchanged by presenters and visitors in the three-day’s diversified program.

Parallel Sessions

Before, during and after the conference, we received warm support and valuable suggestions from the delegates on how to better plan and organize the next conference. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing Galatech-2024 which would be better and more successful. All of us are looking forward to meeting you again in 2024.

Welcome Banquet

Dr. Andrew V. Schally Professor University of Miami, USA	Dr. Vadim T. Ivanov Director Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, RAS, Russia	Dr. Gregg B. Fields Professor & Director Center for Molecular Biology & Biotechnology, Florida Atlantic University, USA
Dr. Alexei V. Finkelstein Professor Institute of Protein Research, RAS, Russia	Dr. Alexei V. Finkelstein Professor Institute of Protein Research, RAS, Russia	Dr. Bernard S. Gerstman Chairman of Department of Physics Florida International University, USA
Dr. Jean-Yves Le Questel Professor Universite de Nantes, France	Dr. Aron B. Fisher Professor & Director Institute for Environmental Medicine, University of Pennsylvania, USA	Dr. SuraiyaRasheed Professor University of Southern California, USA
Dr. JorgBungert Professor University of Florida, USA	Dr. Suren A. Tatulian Professor University of Central Florida, USA	Dr. Donald Jacobs Professor UNC Charlotte, USA
Dr. Tanya W. Moseley Professor University of Texas MD Anderson Cancer Center, USA	Dr. PredragCudic Professor Florida Atlantic University, USA	Dr. Philippe Jais President & CSO Eukarÿs SAS, France
Dr. Sang Hee Lee Director & Professor Myongji University, South Korea	Dr. Bernhard Fischer CEO APEPTICO Forschung und Entwicklung, Austria	Dr. David Urech CSO & Co-CEO Numab AG, USA